Altered mitochondrial metabolism in the insulin‐resistant heart
M Makrecka‐Kuka, E Liepinsh, AJ Murray… - Acta …, 2020 - Wiley Online Library
Obesity‐induced insulin resistance and type 2 diabetes mellitus can ultimately result in
various complications, including diabetic cardiomyopathy. In this case, cardiac dysfunction is …
various complications, including diabetic cardiomyopathy. In this case, cardiac dysfunction is …
Mitochondrial dysfunction in atrial fibrillation—Mechanisms and pharmacological interventions
P Muszyński, TA Bonda - Journal of Clinical Medicine, 2021 - mdpi.com
Despite the enormous progress in the treatment of atrial fibrillation, mainly with the use of
invasive techniques, many questions remain unanswered regarding the pathomechanism of …
invasive techniques, many questions remain unanswered regarding the pathomechanism of …
Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation
Fatty acid oxidation (FAO) is a key bioenergetic pathway often dysregulated in diseases. The
current knowledge on FAO regulators in mammalian cells is limited and sometimes …
current knowledge on FAO regulators in mammalian cells is limited and sometimes …
Disturbed fatty acid oxidation, endoplasmic reticulum stress, and apoptosis in left ventricle of patients with type 2 diabetes
Chronic heart failure is a common complication in patients with type 2 diabetes mellitus
(T2DM). T2DM is associated with disturbed metabolism of fat, which can result in excessive …
(T2DM). T2DM is associated with disturbed metabolism of fat, which can result in excessive …
Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs
C Oyarce, A Vizcaino-Castro, S Chen, A Boerma… - …, 2021 - Taylor & Francis
ABSTRACT M2-like tumor-associated macrophages promote tumor progression by
establishing an immunosuppressive tumor microenvironment. The phenotype and activity of …
establishing an immunosuppressive tumor microenvironment. The phenotype and activity of …
The impact of trimetazidine on cardiac fibrosis, inflammation, and function in ischemic cardiomyopathy patients
NM El-Khodary, AI Ghoneim, AA El-Tayaar… - … drugs and therapy, 2023 - Springer
Background Previous studies have shown that Trimetazidine (TMZ) improves vascular
endothelial function and reduces the inflammatory process progression. However, limited …
endothelial function and reduces the inflammatory process progression. However, limited …
Targeting mitochondria in cardiovascular diseases
F SG Silva, RF Simoes, R Couto… - Current pharmaceutical …, 2016 - ingentaconnect.com
Background: Cardiovascular diseases (CVDs) are one of the main factors responsible for
human morbidity and mortality. Since mitochondria play a critical role in the regulation of …
human morbidity and mortality. Since mitochondria play a critical role in the regulation of …
BSCL2/Seipin deficiency in hearts causes cardiac energy deficit and dysfunction via inducing excessive lipid catabolism
Background Heart failure (HF) is one of the leading causes of death worldwide and is
associated with cardiac metabolic perturbations. Human Type 2 Berardinelli‐Seip …
associated with cardiac metabolic perturbations. Human Type 2 Berardinelli‐Seip …
Trimetazidine Improves Mitochondrial Dysfunction in SOD1G93A Cellular Models of Amyotrophic Lateral Sclerosis through Autophagy Activation
I Salvatori, V Nesci, A Spalloni, V Marabitti… - International Journal of …, 2024 - mdpi.com
Amyotrophic Lateral Sclerosis (ALS) is considered the prototype of motor neuron disease,
characterized by motor neuron loss and muscle waste. A well-established pathogenic …
characterized by motor neuron loss and muscle waste. A well-established pathogenic …
Перспективы применения антигипоксантов в лечении митохондриальных дисфункций
ВЕ Новиков, ОС Левченкова… - Вестник Смоленской …, 2020 - cyberleninka.ru
Цель. Анализ эффективности лекарственных препаратов с преимущественно
антигипоксическим действием в лечении митохондриальных дисфункций (МД) …
антигипоксическим действием в лечении митохондриальных дисфункций (МД) …